Effects of Multimodal Pain Therapy in Patients With Mixed Chronic Pain Syndromes (IMPERApain)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Armin Sablotzki, MD, Klinikum St. Georg gGmbH
ClinicalTrials.gov Identifier:
NCT01346202
First received: April 27, 2011
Last updated: July 12, 2013
Last verified: July 2013
  Purpose

Complex and chronified pain syndromes requires a specialized therapeutic concept. From patients with chronic low back pain the investigators know, that an interdisciplinary multi-modal approach may improve the therapeutic success. In this observational study the investigators investigated if the multi-modal pain therapy is also effective in patients with mixed chronic pain syndromes.


Condition
Chronic Pain

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Influence of a Multimodal Day-unit Pain Therapy on Pain Experience, Pain-related Disability and Depression in Patients With Chronic Pain Syndromes

Resource links provided by NLM:


Further study details as provided by Klinikum St. Georg gGmbH:

Primary Outcome Measures:
  • intensity of pain [ Time Frame: Change from Baseline in intensity of pain at 1 year ] [ Designated as safety issue: No ]
    pain intensity 1 year after multi-modale therapy compared with pain intensity before treatment


Secondary Outcome Measures:
  • pain disability index [ Time Frame: Change from Baseline in pain disability index at 6 months ] [ Designated as safety issue: No ]
    pain disability index 6 month after multi-modale therapy compared with pain disability index before treatment


Enrollment: 260
Study Start Date: January 2011
Study Completion Date: July 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic pain
260 consecutive patients with verified chronic pain syndromes

Detailed Description:

The multi-modal pain therapy includes:

  • specific drug therapy
  • pain education
  • psychological therapy
  • physical therapy
  • behavioral therapy
  • work hardening
  • bio-feedback
  • ergotherapy
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

260 consecutive patients with chronic pain syndromes

Criteria

Inclusion Criteria:

  • age >= 18 years and <= 65 years
  • verified chronic pain for more than 6 month

Exclusion Criteria:

  • application for a pension
  • non-accordance with multi-modal pain therapy
  • dominant geriatric symptoms
  • dominant psychiatric symptoms
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01346202

Locations
Germany
Klinikum St. Georg, Pain Center
Leipzig, Sachsen, Germany, 04129
Sponsors and Collaborators
Klinikum St. Georg gGmbH
Investigators
Principal Investigator: Armin R Sablotzki, MD, PhD Klinikum St. Georg
  More Information

Additional Information:
No publications provided

Responsible Party: Armin Sablotzki, MD, Prof. Dr. med., Klinikum St. Georg gGmbH
ClinicalTrials.gov Identifier: NCT01346202     History of Changes
Other Study ID Numbers: EK-BR-28/10-1
Study First Received: April 27, 2011
Last Updated: July 12, 2013
Health Authority: Germany: Ethics Commission

Keywords provided by Klinikum St. Georg gGmbH:
multi-modal pain therapy, chronic pain

Additional relevant MeSH terms:
Chronic Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on October 01, 2014